{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T08:56:28Z","timestamp":1768812988064,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T00:00:00Z","timestamp":1699574400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,10]]},"abstract":"<jats:p>To investigate and analyze changes in the expression level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer (NSCLC). In the present study, Gene Expression Omnibus (GEO), Targetscan, starBase, and Metastases databases were retrieved for bioinformatics analysis. qRT-PCR was conducted to determine the expression level of miR-193b-3p in the serum or tissues of NSCLC patients. The correlation between the expression level of serum miR-193b-3p and the clinical characteristics of NSCLC patients was analyzed, and receiver operating characteristic (ROC) curves were analyzed to assess the diagnostic significance of serum expression of miR-193b-3p in NSCLC. The GEO2R tool was used to analyze the GSE102286 dataset in the GEO database, indicating that miR-193b-3p is one of the overexpressed miRNAs in NSCLC. Databases, such as TargetScan and starBase, were used to predict miR-193b-3p target genes. Finally, 153 target genes were retrieved, and gene ontology (GO) and KEGG analyses were conducted based on the Metascape database, which indicated that all 153 target genes participated in multiple biological processes and signaling pathways closely correlated with the genesis and progression of NSCLC. miR-193b-3p is highly expressed in the serum and cancer tissues of patients with NSCLC. The high miR-193b-3p expression group had a lower degree of cancer differentiation, a higher proportion of late TNM stage, and a greater incidence of lymph node metastasis. ROC curve analysis reported that the area under the curve was 0.89 (95% CI: 0.85\u20130.92). High miR-193b-3p expression levels were detected in NSCLC patients and were closely correlated with the degree of malignancy in NSCLC. miR-193b-3p expression levels have a diagnostic effect on NSCLC.<\/jats:p>","DOI":"10.1097\/md.0000000000035918","type":"journal-article","created":{"date-parts":[[2023,11,10]],"date-time":"2023-11-10T19:05:54Z","timestamp":1699643154000},"page":"e35918","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2680-609X","authenticated-orcid":false,"given":"Feng","family":"Xiao","sequence":"first","affiliation":[{"name":"Department of Pathology, Affiliated Nantong Hospital 3 of Nantong University (Nantong Third People\u2019s Hospital), Nantong, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Nantong Hospital 3 of Nantong University (Nantong Third People\u2019s Hospital), Nantong, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiping","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Nantong Hospital 3 of Nantong University (Nantong Third People\u2019s Hospital), Nantong, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaolun","family":"An","sequence":"additional","affiliation":[{"name":"Cardiothoracic Surgery, Affiliated Nantong Hospital 3 of Nantong University (Nantong Third People\u2019s Hospital), Nantong, Jiangsu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1563-0063","authenticated-orcid":false,"given":"Chunyan","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Affiliated Nantong Hospital 3 of Nantong University (Nantong Third People\u2019s Hospital), Nantong, Jiangsu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.3390\/jcm9113543","article-title":"New target therapies in advanced non-small cell lung cancer: a review of the literature and future perspectives.","volume":"9","author":"de Mello","year":"2020","journal-title":"J Clin Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3389\/fmolb.2018.00076","article-title":"Molecular diagnostics in clinical oncology.","volume":"5","author":"Sokolenko","year":"2018","journal-title":"Front Mol Biosci"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00262-019-02310-2","article-title":"Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors.","volume":"68","author":"Nadal","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"8002","DOI":"10.3390\/ijms21218002","article-title":"Beyond conventional: the new horizon of anti-angiogenic microRNAs in non-small cell lung cancer therapy.","volume":"21","author":"Tirpe","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/bib\/bby063","article-title":"A brief history of bioinformatics.","volume":"20","author":"Gauthier","year":"2019","journal-title":"Brief Bioinform"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"220070","DOI":"10.1098\/rsob.220070","article-title":"miR-155-3p: processing by-product or rising star in immunity and cancer?","volume":"12","author":"Dawson","year":"2022","journal-title":"Open Biol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"629611","DOI":"10.3389\/fphar.2021.629611","article-title":"The causes and consequences of miR-503 dysregulation and its impact on cardiovascular disease and cancer.","volume":"12","author":"He","year":"2021","journal-title":"Front Pharmacol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41419-020-03192-4","article-title":"Unveiling the ups and downs of miR-205 in physiology and cancer: transcriptional and post-transcriptional mechanisms.","volume":"11","author":"Ferrari","year":"2020","journal-title":"Cell Death Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bbcan.2018.03.002","article-title":"HOX cluster-embedded micro-RNAs and cancer.","volume":"1869","author":"Fantini","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"R10-20250504","first-page":"1","article-title":"Micro-RNAs: the new potential biomarkers in cancer diagnosis, prognosis, and cancer therapy.","volume":"61","author":"Mansoori","year":"2015","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.jtho.2020.04.028","article-title":"Lung cancer in the People\u2019s Republic of China.","volume":"15","author":"Gao","year":"2020","journal-title":"J Thorac Oncol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3322\/caac.21632","article-title":"Outdoor air pollution and cancer: an overview of the current evidence and public health recommendations.","volume":"70","author":"Turner","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"R13-20250504","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-023-00611-y","article-title":"microRNAs in action: biogenesis, function and regulation.","author":"Shang","year":"2023","journal-title":"Nat Rev Genet"},{"key":"R14-20250504","first-page":"1373","article-title":"Mesenchymal stem cell-derived microRNAs: friends or foes of tumor cells?","volume":"38","author":"Harrell","year":"2023","journal-title":"Histol Histopathol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3390\/jpm13050719","article-title":"Modulation of ferroptosis by microRNAs in human cancer.","volume":"13","author":"Velkova","year":"2023","journal-title":"J Pers Med"},{"key":"R16-20250504","first-page":"710","article-title":"Dynamic role of exosome microRNAs in cancer cell signaling and their emerging role as noninvasive biomarkers.","volume":"12","author":"Aseervatham","year":"2023","journal-title":"Biology (Basel)"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"D991","DOI":"10.1093\/nar\/gks1193","article-title":"NCBI GEO: archive for functional genomics data sets--update.","volume":"41","author":"Barrett","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13062-023-00356-y","article-title":"M2 macrophage-derived exosomal miR-193b-3p promotes progression and glutamine uptake of pancreatic cancer by targeting TRIM62.","volume":"18","author":"Zhang","year":"2023","journal-title":"Biol Direct"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/16078454.2021.1997197","article-title":"Circ_0000745 regulates NOTCH1-mediated cell proliferation and apoptosis in pediatric T-cell acute lymphoblastic leukemia through adsorbing miR-193b-3p.","volume":"26","author":"Feng","year":"2021","journal-title":"Hematology"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3892\/mmr.2020.11729","article-title":"Long non-coding RNA SNHG14 affects the proliferation and apoptosis of childhood acute myeloid leukemia cells by modulating the miR-193b-3p\/MCL1 axis.","volume":"23","author":"Wang","year":"2021","journal-title":"Mol Med Rep"},{"key":"R21-20250504","first-page":"3630","article-title":"Long non-coding RNA LINC00152 promotes tumorigenesis via sponging miR-193b-3p in osteosarcoma.","volume":"18","author":"Liu","year":"2019","journal-title":"Oncol Lett"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40659-018-0192-5","article-title":"Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.","volume":"51","author":"Song","year":"2018","journal-title":"Biol Res"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1002\/jcb.27751","article-title":"MORC4 is a novel breast cancer oncogene regulated by miR-193b-3p.","volume":"120","author":"Yang","year":"2019","journal-title":"J Cell Biochem"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.biopha.2017.11.086","article-title":"miR-193b-3p possesses anti-tumor activity in ovarian carcinoma cells by targeting p21-activated kinase 3.","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"16861","DOI":"10.1002\/jcp.28368","article-title":"miR-193: a new weapon against cancer.","volume":"234","author":"Khordadmehr","year":"2019","journal-title":"J Cell Physiol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1827.2011.02776.x","article-title":"Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.","volume":"62","author":"Song","year":"2012","journal-title":"Pathol Int"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"djt356","DOI":"10.1093\/jnci\/djt356","article-title":"Wnt signaling pathway in non-small cell lung cancer.","volume":"106","author":"Stewart","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.7150\/thno.24401","article-title":"HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.","volume":"8","author":"Yang","year":"2018","journal-title":"Theranostics"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fphar.2017.00532","article-title":"E-M, an engineered endostatin with high ATPase activity, inhibits the recruitment and alternative activation of macrophages in non-small cell lung cancer.","volume":"8","author":"Xu","year":"2017","journal-title":"Front Pharmacol"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1080\/21541248.2019.1684785","article-title":"PKCepsilon regulates Rho GTPases and actin cytoskeleton reorganization in non-small cell lung cancer cells.","volume":"12","author":"Cooke","year":"2021","journal-title":"Small GTPases"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035918","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T02:29:30Z","timestamp":1746325770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000035918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,10]]},"references-count":30,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000035918","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,10]]}}}